Insulin-like Growth Factors and Breast Cancer
Author Information
Author(s): H Yu, MA Levesque, MJ Khosravi, A Papanastasiou-Diamandi, GM Clark, EP Diamandis
Primary Institution: Mount Sinai Hospital, University of Toronto, and University of Texas Health Science Center at San Antonio
Hypothesis
Are insulin-like growth factors and their binding proteins associated with prognostic indicators in breast cancer?
Conclusion
High levels of IGF-II and IGFBP-3 are associated with unfavorable prognostic markers in breast cancer.
Supporting Evidence
- IGF-II was positively correlated with IGFBP-3.
- IGFBP-3 was positively associated with S-phase fraction.
- Both IGF-II and IGFBP-3 were inversely associated with the estrogen receptor.
Takeaway
This study looked at proteins related to growth in breast cancer and found that some of them are linked to worse outcomes.
Methodology
Measured levels of IGF-I, IGF-II, IGFBP-1, IGFBP-3, and PSA in tumor tissue cytosols from 200 women with primary breast cancer.
Limitations
Clinical and follow-up information of the patients was not available.
Participant Demographics
Women with primary breast cancer.
Want to read the original?
Access the complete publication on the publisher's website